The global polymer-based prefilled syringe market is anticipated to reach a valuation of US$ 7.2 billion in 2023, driven by rising prevalence of chronic diseases. The trend is expected to create new opportunities for the market, leading to a projected CAGR of 9.0% between 2023 and 2033, and reaching a total valuation of approximately US$ 17.1 billion by 2033. One of the major factors...